View Clinical Trial (Medical Research Study)
Study Comparing Premarin®/MPA, PREMPRO® and Provera® in Healthy Postmenopausal Women - NCT00543634-68154(Clinical Trial 187499)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Omaha |
|
State:
|
|
NE |
| Zip Code: |
|
68154 |
| Conditions: |
|
Postmenopause |
| Purpose: |
|
The purpose of the study is to evaluate the safety and efficacy of new tablet formulations
of Premarin®/medroxyprogesterone (MPA).
|
| Study summary: |
|
|
| Criteria: |
|
- Healthy postmenopausal women aged 35 to 70 years with spontaneous or surgical
amenorrhea
- BMI in the range of 18 to 35 kg/m2
- History or presence of hypertension (>139 mm Hg systolic or >89 mm Hg diastolic)
- History of drug allergy, particularly to conjugated estrogens (CE) or selective
estrogen receptor modulators (SERMs)
- Use of any prescription or investigational drug within 30 days before test article
administration |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
June 22, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|